M&AHealthcareSIGNED
Novo Partners with Anthropic to Accelerate Obesity Drug Development with Claude AI
Acquirer
Novo Nordisk
Target
Anthropic
Novo Nordisk is partnering with Anthropic to accelerate the development of obesity drugs using Claude AI. The pharmaceutical company aims to become the world's most AI-driven healthcare company and discover new scientific opportunities.
The Meridian Weekly
The week's largest deals and the Iberian ones, every Monday. Free.